血清视黄酸结合蛋白与冠状动脉造影后造影剂肾病发生相关性的研究(3)
第1页 |
参见附件。
[参考文献]
[1] Soma VR,Cavusoglu E,Vidhun R,et al.Contrast-associated nephropathy[J].Heart Dis,2002,4(6):372-379.
[2] Senoo T,Motohiro M,Kamihata H,et al.Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome[J].Am J Cardiol,2010,105(5):624-628.
[3] Solomon RJ,Mehran R,Natarajan MK,et al.Contrast-induced nephropathy and long- term adverse events:cause and effect[J].Clin J Am Soc Nephrol,2009,4(7):1162-1169.
[4] Thomson VS,Narayanan K,Singh JC.Contrast induced nephropathy in urology[J].Indian J Urol,2009,5(4):437-445.
(下转第页)
(上接第页)
[5] Ling W,Zhao HN,Ben H,et al.Urinary IL -18 and NGAL as early predictive biomarkers in contrast-induced nephropathy -fter coronary an iography[J].Nephron Clin Pract,2008,108(3):c176-c181.
[6] 冯霞,崔炜.造影剂肾病发病机制及防治研究进展[J].中华实用诊断与治疗杂志,2010,24(9):835-837
[7] 金宏.视黄醇转运的分子机制[J].生理学进展,1997,29:166-168.
[8] Marino M,Andrews D,Brown D,et al.Transcytosisof retino-l binding protein across renal prox imal tuble cells after megalin(gp330)-mediated endocytosis[J].Am Soc Nephrol,2001,12:637-648.
[9] 邓燕,高梅.视黄醇结合蛋白在糖尿病肾病早期诊断中的作用[J].检验医学与临床,2009,6(23):2057.
(收稿日期:2013-10-21)
您现在查看是摘要介绍页,详见PDF附件。